Prime Medicine
PRME
PRME
105 hedge funds and large institutions have $433M invested in Prime Medicine in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 26 increasing their positions, 27 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
105
Holders Change
+22
Holders Change %
+26.51%
% of All Funds
1.54%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
34
Increased
26
Reduced
27
Closed
12
Calls
$375K
Puts
$558K
Net Calls
-$183K
Net Calls Change
-$270K
Top Buyers
1 |
AIM
1
ARK Investment Management
St. Petersburg,
Florida
|
$27.8M |
2 |
2
BlackRock
New York
|
$33.5M |
3 |
3
Morgan Stanley
New York
|
$3.75M |
4 |
BG
4
Bollard Group
Boston,
Massachusetts
|
$3.2M |
5 |
5
Two Sigma Investments
New York
|
$2.38M |